HEADER HYDROLASE/HYDROLASE INHIBITOR 03-FEB-23 8G1W TITLE CRYSTAL STRUCTURE MATRIPTASE (C731S) IN COMPLEX WITH INHIBITOR VD4162B COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUPPRESSOR OF TUMORIGENICITY 14 PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 615-855; COMPND 5 SYNONYM: MATRIPTASE,MEMBRANE-TYPE SERINE PROTEASE 1,MT-SP1,PROSTAMIN, COMPND 6 SERINE PROTEASE 14,SERINE PROTEASE TADG-15,TUMOR-ASSOCIATED COMPND 7 DIFFERENTIALLY-EXPRESSED GENE 15 PROTEIN; COMPND 8 EC: 3.4.21.109; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: CYCLIC PEPTIDE INHIBITOR (ACE)Y(DTR)(NLE)(THZ); COMPND 13 CHAIN: M; COMPND 14 ENGINEERED: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: CYCLIC PEPTIDE INHIBITOR (ACE)Y(DTR)(NLE)(KCM); COMPND 17 CHAIN: L; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ST14, PRSS14, SNC19, TADG15; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 13 ORGANISM_TAXID: 32630; SOURCE 14 MOL_ID: 3; SOURCE 15 SYNTHETIC: YES; SOURCE 16 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 17 ORGANISM_TAXID: 32630 KEYWDS MATRIPTASE, INHIBITOR COMPLEX, HYDROLASE, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.LOVELL,M.M.KASHIPATHY,K.P.BATTAILE,J.W.JANETKA REVDAT 3 10-APR-24 8G1W 1 JRNL REVDAT 2 27-MAR-24 8G1W 1 JRNL REVDAT 1 07-FEB-24 8G1W 0 JRNL AUTH V.C.DAMALANKA,V.BANAS,P.DE BONA,M.M.KASHIPATHY,K.BATTAILE, JRNL AUTH 2 S.LOVELL,J.W.JANETKA JRNL TITL MECHANISM-BASED MACROCYCLIC INHIBITORS OF SERINE PROTEASES. JRNL REF J.MED.CHEM. V. 67 4833 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38477709 JRNL DOI 10.1021/ACS.JMEDCHEM.3C02388 REMARK 2 REMARK 2 RESOLUTION. 1.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19_4084 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.37 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.100 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 73999 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.149 REMARK 3 R VALUE (WORKING SET) : 0.148 REMARK 3 FREE R VALUE : 0.166 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 3736 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.3700 - 3.6000 1.00 2657 151 0.1406 0.1528 REMARK 3 2 3.6000 - 2.8600 1.00 2638 132 0.1442 0.1537 REMARK 3 3 2.8600 - 2.5000 1.00 2607 139 0.1548 0.1519 REMARK 3 4 2.5000 - 2.2700 0.99 2629 136 0.1404 0.1391 REMARK 3 5 2.2700 - 2.1100 0.99 2609 134 0.1332 0.1585 REMARK 3 6 2.1100 - 1.9800 1.00 2642 125 0.1300 0.1301 REMARK 3 7 1.9800 - 1.8800 1.00 2589 139 0.1334 0.1628 REMARK 3 8 1.8800 - 1.8000 1.00 2608 143 0.1360 0.1495 REMARK 3 9 1.8000 - 1.7300 1.00 2634 121 0.1392 0.1708 REMARK 3 10 1.7300 - 1.6700 1.00 2591 124 0.1393 0.1735 REMARK 3 11 1.6700 - 1.6200 0.99 2598 156 0.1322 0.1684 REMARK 3 12 1.6200 - 1.5700 1.00 2585 142 0.1395 0.1650 REMARK 3 13 1.5700 - 1.5300 1.00 2600 152 0.1408 0.1826 REMARK 3 14 1.5300 - 1.4900 1.00 2581 145 0.1547 0.1973 REMARK 3 15 1.4900 - 1.4600 1.00 2621 143 0.1576 0.1937 REMARK 3 16 1.4600 - 1.4300 1.00 2618 134 0.1620 0.2441 REMARK 3 17 1.4300 - 1.4000 1.00 2592 127 0.1679 0.2197 REMARK 3 18 1.4000 - 1.3700 1.00 2559 164 0.1722 0.2166 REMARK 3 19 1.3700 - 1.3500 1.00 2604 136 0.1801 0.2484 REMARK 3 20 1.3500 - 1.3300 1.00 2619 138 0.1857 0.2129 REMARK 3 21 1.3300 - 1.3000 0.99 2586 122 0.1902 0.2215 REMARK 3 22 1.3000 - 1.2800 0.99 2600 134 0.2012 0.2439 REMARK 3 23 1.2800 - 1.2700 0.99 2611 134 0.2066 0.2185 REMARK 3 24 1.2700 - 1.2500 0.99 2541 149 0.2166 0.2302 REMARK 3 25 1.2500 - 1.2300 0.99 2606 131 0.2277 0.2831 REMARK 3 26 1.2300 - 1.2200 0.99 2555 146 0.2417 0.2346 REMARK 3 27 1.2200 - 1.2000 0.99 2583 139 0.2630 0.2896 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.800 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2046 REMARK 3 ANGLE : 1.164 2791 REMARK 3 CHIRALITY : 0.088 286 REMARK 3 PLANARITY : 0.009 362 REMARK 3 DIHEDRAL : 15.228 707 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8G1W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1000272072. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74030 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.03200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.22 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.45700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3NCL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2M SODIUM FORMATE, 100 SODIUM ACETATE, REMARK 280 PH 4.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 37.62950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.12400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 37.62950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 40.12400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, M, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1074 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1157 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1212 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1251 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 814 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 635 CG CD1 CD2 REMARK 470 ARG A 662 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 851 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR M 2 C DTR M 3 N 0.160 REMARK 500 DTR M 3 C NLE M 4 N 0.142 REMARK 500 NLE M 4 C THZ M 5 N 0.182 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 825 -65.32 -121.39 REMARK 500 REMARK 500 REMARK: NULL DBREF 8G1W A 615 855 UNP Q9Y5Y6 ST14_HUMAN 615 855 DBREF 8G1W M 1 5 PDB 8G1W 8G1W 1 5 DBREF 8G1W L 1 5 PDB 8G1W 8G1W 1 5 SEQADV 8G1W SER A 731 UNP Q9Y5Y6 CYS 731 ENGINEERED MUTATION SEQRES 1 A 241 VAL VAL GLY GLY THR ASP ALA ASP GLU GLY GLU TRP PRO SEQRES 2 A 241 TRP GLN VAL SER LEU HIS ALA LEU GLY GLN GLY HIS ILE SEQRES 3 A 241 CYS GLY ALA SER LEU ILE SER PRO ASN TRP LEU VAL SER SEQRES 4 A 241 ALA ALA HIS CYS TYR ILE ASP ASP ARG GLY PHE ARG TYR SEQRES 5 A 241 SER ASP PRO THR GLN TRP THR ALA PHE LEU GLY LEU HIS SEQRES 6 A 241 ASP GLN SER GLN ARG SER ALA PRO GLY VAL GLN GLU ARG SEQRES 7 A 241 ARG LEU LYS ARG ILE ILE SER HIS PRO PHE PHE ASN ASP SEQRES 8 A 241 PHE THR PHE ASP TYR ASP ILE ALA LEU LEU GLU LEU GLU SEQRES 9 A 241 LYS PRO ALA GLU TYR SER SER MET VAL ARG PRO ILE SER SEQRES 10 A 241 LEU PRO ASP ALA SER HIS VAL PHE PRO ALA GLY LYS ALA SEQRES 11 A 241 ILE TRP VAL THR GLY TRP GLY HIS THR GLN TYR GLY GLY SEQRES 12 A 241 THR GLY ALA LEU ILE LEU GLN LYS GLY GLU ILE ARG VAL SEQRES 13 A 241 ILE ASN GLN THR THR CYS GLU ASN LEU LEU PRO GLN GLN SEQRES 14 A 241 ILE THR PRO ARG MET MET CYS VAL GLY PHE LEU SER GLY SEQRES 15 A 241 GLY VAL ASP SER CYS GLN GLY ASP SER GLY GLY PRO LEU SEQRES 16 A 241 SER SER VAL GLU ALA ASP GLY ARG ILE PHE GLN ALA GLY SEQRES 17 A 241 VAL VAL SER TRP GLY ASP GLY CYS ALA GLN ARG ASN LYS SEQRES 18 A 241 PRO GLY VAL TYR THR ARG LEU PRO LEU PHE ARG ASP TRP SEQRES 19 A 241 ILE LYS GLU ASN THR GLY VAL SEQRES 1 M 5 ACE TYR DTR NLE THZ SEQRES 1 L 5 ACE TYR DTR NLE KCM HET ACE M 1 3 HET DTR M 3 14 HET NLE M 4 8 HET THZ M 5 20 HET ACE L 1 3 HET DTR L 3 14 HET NLE L 4 8 HET KCM L 5 20 HET CL A 901 1 HETNAM ACE ACETYL GROUP HETNAM DTR D-TRYPTOPHAN HETNAM NLE NORLEUCINE HETNAM THZ 1-[(4S)-4-AMINO-5-(1,3-BENZOTHIAZOL-2-YL)-5- HETNAM 2 THZ OXOPENTYL]GUANIDINE HETNAM KCM N-[(4S,5S)-4-AMINO-5-(1,3-BENZOTHIAZOL-2-YL)-5- HETNAM 2 KCM HYDROXYPENTYL]GUANIDINE HETNAM CL CHLORIDE ION FORMUL 2 ACE 2(C2 H4 O) FORMUL 2 DTR 2(C11 H12 N2 O2) FORMUL 2 NLE 2(C6 H13 N O2) FORMUL 2 THZ C13 H17 N5 O S FORMUL 3 KCM C13 H19 N5 O S FORMUL 4 CL CL 1- FORMUL 5 HOH *258(H2 O) HELIX 1 AA1 ALA A 654 ILE A 659 5 6 HELIX 2 AA2 ASP A 668 THR A 670 5 3 HELIX 3 AA3 ASN A 772 LEU A 780 1 9 HELIX 4 AA4 PHE A 845 GLY A 854 1 10 SHEET 1 AA1 8 THR A 619 ASP A 620 0 SHEET 2 AA1 8 GLN A 764 VAL A 770 -1 O LYS A 765 N THR A 619 SHEET 3 AA1 8 MET A 788 GLY A 792 -1 O GLY A 792 N ARG A 769 SHEET 4 AA1 8 GLY A 837 ARG A 841 -1 O TYR A 839 N MET A 789 SHEET 5 AA1 8 ILE A 818 TRP A 826 -1 N TRP A 826 O VAL A 838 SHEET 6 AA1 8 PRO A 808 VAL A 812 -1 N SER A 811 O PHE A 819 SHEET 7 AA1 8 ALA A 744 GLY A 749 -1 N TRP A 746 O SER A 810 SHEET 8 AA1 8 GLN A 764 VAL A 770 -1 O ILE A 768 N ILE A 745 SHEET 1 AA2 7 GLN A 629 ALA A 634 0 SHEET 2 AA2 7 GLY A 638 LEU A 645 -1 O CYS A 641 N LEU A 632 SHEET 3 AA2 7 TRP A 650 SER A 653 -1 O VAL A 652 N SER A 644 SHEET 4 AA2 7 ALA A 713 LEU A 717 -1 O ALA A 713 N SER A 653 SHEET 5 AA2 7 GLN A 690 SER A 699 -1 N ILE A 698 O LEU A 714 SHEET 6 AA2 7 TRP A 672 LEU A 676 -1 N ALA A 674 O ARG A 692 SHEET 7 AA2 7 GLN A 629 ALA A 634 -1 N HIS A 633 O THR A 673 SSBOND 1 CYS A 641 CYS A 657 1555 1555 2.02 SSBOND 2 CYS A 776 CYS A 790 1555 1555 2.04 SSBOND 3 CYS A 801 CYS A 830 1555 1555 2.04 LINK OG SER A 805 C40 KCM L 5 1555 1555 1.41 LINK C ACE M 1 N TYR M 2 1555 1555 1.45 LINK C TYR M 2 N DTR M 3 1555 1555 1.50 LINK OH TYR M 2 CE NLE M 4 1555 1555 1.41 LINK C DTR M 3 N NLE M 4 1555 1555 1.48 LINK C NLE M 4 N THZ M 5 1555 1555 1.52 LINK C ACE L 1 N TYR L 2 1555 1555 1.44 LINK C TYR L 2 N DTR L 3 1555 1555 1.44 LINK OH TYR L 2 CE NLE L 4 1555 1555 1.41 LINK C DTR L 3 N NLE L 4 1555 1555 1.44 LINK C NLE L 4 N30 KCM L 5 1555 1555 1.43 CISPEP 1 TYR L 2 DTR L 3 0 -0.33 CRYST1 75.259 80.248 40.361 90.00 95.45 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013287 0.000000 0.001269 0.00000 SCALE2 0.000000 0.012461 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024889 0.00000